3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Myeloid, Acute
5
Myelodysplastic Syndromes
4
Burkitt Lymphoma
3
Blast Crisis
3
Anemia, Refractory, with Excess of Blasts
3
Primary Myelofibrosis
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Myeloproliferative Disorders
2
Multiple Myeloma
2
Lymphoma, T-Cell
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia
2
Hodgkin Disease
2
Congenital Abnormalities
2
Waldenstrom Macroglobulinemia
1
Thrombocythemia, Essential
1
Smoldering Multiple Myeloma
1
Sezary Syndrome
1
Recurrence
1
Precancerous Conditions
1
Polycythemia Vera
1
Plasmablastic Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neoplasms, Plasma Cell
1
Myelodysplastic-Myeloproliferative Diseases
1
Interventions
Nivolumab
22
Specimen Handling
17
pembrolizumab
13
cabozantinib
13
Magnetic Resonance Spectroscopy
13
belzutifan
12
Ipilimumab
12
lenvatinib
7
Axitinib
7
CTLA-4 Antigen
6
Biopsy
6
atezolizumab
4
Sunitinib
4
tivozanib
3
Surveys and Questionnaires
3
Immunoglobulin G
3
Everolimus
3
Disulfides
3
relatlimab
2
pazopanib
2
palbociclib
2
aldesleukin
2
Watchful Waiting
2
Standard of Care
2
Radiosurgery
2
Practice Guidelines as Topic
2
Nephrectomy
2
Bevacizumab
2
zimberelimab
1
ulixertinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
Peripheral Blood Stem Cell Transplantation
×
30 days
×
Clear all
No trials found.